Journal of Ophthalmology / 2016 / Article / Tab 2

Research Article

How Important Is the Etiology in the Treatment of Epiphora?

Table 2

Causes of epiphora and the relationship with treatment methods and treatment rates.

Patients (/%)Treatment modality (med/sur)Untreated patients (%) value

(1) Ocular surface disease63 (38.7)Med65.070.000
(a) Dry eye/blepharitis63 (38.7)Med65.070.000

(2) Lacrimal pathway diseases79 (48.4)0.000
(a) Chronic dacryocystitis36 (22.1)Surg88.80.000
(b) Congenital lacrimal stenosis5 (3.06)Surg1000.000
(c) Punctum stenosis42 (25.8)Surg69.040.000

(3) Eyelid disorders35 (21.4)0.000
(a) Ectropion27 (16.6)Surg70.30.000
(b) Entropion5 (3.06)Surg800.000
(c) Trichiasis/distichiasis6 (3.6)0.000

(4) Others4 (2.4)Med/Surg250.000

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.